Annual SG&A
$86.24M$32.05M+59.14%
Summary
- Current Value
- As of today, RNA annual SG&A is $86.24M, up +59.14% on
- Historical Performance
- RNA annual SG&A is up +229.22% over the past 3 years, and up +1587.01% over the past 5 years
- All-Time High Comparison
- RNA annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- RNA annual SG&A is +128.55% above its 3-year low of $37.73M reached on an earlier date
- Sector Comparison
- RNA annual SG&A is higher than 81.23% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $86.24M | +59.1% | +229.2% | +1587.0% | +3433.0% | |
| Quarterly SG&A | $46.33M | +99.1% | +359.0% | +1133.2% | +4980.4% | |
| TTM SG&A | -$4.41B | -6055.9% | -10000.0% | -10000.0% | -10000.0% | |
| Price | $72.37 | +135.0% | +264.9% | +185.8% | – | |
| Annual Operating Expenses | $389.83M | +59.0% | +206.1% | +1883.8% | +3484.0% | |
| Annual Operating Profit | -$378.94M | -60.8% | -221.0% | -2086.3% | -3509.6% | |
| Annual D&A | $2.78M | +32.1% | +334.4% | +697.7% | +624.8% | |
| Annual Revenue | $10.90M | +14.0% | +16.9% | +369.9% | +2775.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $86.24M | at high | |
| 5Y | $86.24M | at high | |
| All | $86.24M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $37.73M | N/A | +128.6% |
| 5Y | $13.46M | N/A | +540.6% |
| All | $2.44M | +3433.0% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $86.24M | +59.1% | |
| $54.19M | +43.6% | |
| $37.73M | +44.0% | |
| $26.20M | +94.6% |
| Year | Value | Change |
|---|---|---|
| $13.46M | +163.3% | |
| $5.11M | +109.4% | |
| $2.44M | - |
FAQ
What is the current annual SG&A of RNA?
As of today, RNA annual SG&A is $86.24M
What is 1-year change in RNA annual SG&A?
RNA annual SG&A is up +59.14% year-over-year
What is 3-year change in RNA annual SG&A?
RNA annual SG&A is up +229.22% over the past 3 years
How far is RNA annual SG&A from its all-time high?
RNA annual SG&A is currently at its all-time high
How does RNA annual SG&A rank versus sector peers?
RNA annual SG&A is higher than 81.23% of companies in Healthcare sector
When is RNA next annual earnings release?
The next annual earnings release for RNA is on
Quarterly SG&A
$46.33M$9.47M+25.69%
Summary
- Current Value
- As of today, RNA quarterly SG&A is $46.33M, up +25.69% on
- Historical Performance
- RNA quarterly SG&A is up +99.08% year-over-year, and up +359.02% over the past 3 years
- All-Time High Comparison
- RNA quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- RNA quarterly SG&A is +346.20% above its 3-year low of $10.38M reached on an earlier date
- Sector Comparison
- RNA quarterly SG&A is higher than 85.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $46.33M | +25.7% | +99.1% | +359.0% | +1133.2% | |
| Annual SG&A | $86.24M | – | +59.1% | +229.2% | +1587.0% | |
| TTM SG&A | -$4.41B | -3711.4% | -6055.9% | -10000.0% | -10000.0% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| Quarterly Operating Expenses | $200.23M | +15.0% | +100.7% | +325.9% | +1646.3% | |
| Quarterly Operating Profit | -$188.81M | -10.3% | -92.4% | -320.2% | -1546.7% | |
| Quarterly D&A | $1.06M | +29.7% | +48.7% | +185.4% | +945.5% | |
| Quarterly Revenue | $12.48M | +224.3% | +434.0% | +402.6% | +614.5% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $46.33M | at high | |
| 3Y | $46.33M | at high | |
| 5Y | $46.33M | at high | |
| All | $46.33M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $28.34M | N/A | +63.5% |
| 3Y | $10.38M | N/A | +346.2% |
| 5Y | $4.82M | N/A | +862.1% |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of RNA?
As of today, RNA quarterly SG&A is $46.33M
What is RNA quarterly SG&A most recent change?
RNA quarterly SG&A was up +25.69% on September 30, 2025
What is 1-year change in RNA quarterly SG&A?
RNA quarterly SG&A is up +99.08% year-over-year
How far is RNA quarterly SG&A from its all-time high?
RNA quarterly SG&A is currently at its all-time high
How does RNA quarterly SG&A rank versus sector peers?
RNA quarterly SG&A is higher than 85.47% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM SG&A
-$4.41B$549.79M-14.25%
Summary
- Current Value
- As of today, RNA TTM SG&A is -$4.41B, down -14.25% on
- Historical Performance
- RNA TTM SG&A is down -6055.95% year-over-year, and down -12775.83% over the past 3 years
- All-Time High Comparison
- RNA TTM SG&A is currently -19772.23% below its historical high of -$22.19M set on an earlier date
- 3-Year Low Comparison
- RNA TTM SG&A is at its 3-year low
- Sector Comparison
- RNA TTM SG&A is higher than 11.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$4.41B | -3711.4% | -6055.9% | -10000.0% | -10000.0% | |
| Annual SG&A | $86.24M | – | +59.1% | +229.2% | +1587.0% | |
| Quarterly SG&A | $46.33M | +25.7% | +99.1% | +359.0% | +1133.2% | |
| Price | $72.37 | +54.1% | +135.0% | +264.9% | +185.8% | |
| TTM Operating Profit | -$612.46M | -17.4% | -88.6% | -272.9% | -1699.7% | |
| TTM D&A | $3.39M | +11.4% | +580.0% | +179.5% | +475.1% | |
| TTM Revenue | $20.87M | +94.5% | +106.3% | +151.2% | +242.7% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.03B | N/A | -45.3% |
| 3Y | -$1.15B | N/A | -283.4% |
| 5Y | -$183.90M | N/A | -2297.3% |
| All | -$22.19M | N/A | >-9999.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.41B | N/A | at low |
| 3Y | -$4.41B | N/A | at low |
| 5Y | -$4.41B | N/A | at low |
| All | -$4.41B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of RNA?
As of today, RNA TTM SG&A is -$4.41B
What is RNA TTM SG&A most recent change?
RNA TTM SG&A was down -14.25% on September 30, 2025
What is 1-year change in RNA TTM SG&A?
RNA TTM SG&A is down -6055.95% year-over-year
How does RNA TTM SG&A rank versus sector peers?
RNA TTM SG&A is higher than 11.32% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna